News

NIH expands cancer research program to include breast density


 

References

Officials at the National Institutes of Health are taking a closer look at the role that breast density plays in the development of breast cancer.

As part of the agency’s Breast Cancer and the Environment Research Program (BCERP), grant-funded researchers are being tasked with expanding the study of risk factors that precede breast cancer such as breast density. They will also include more racially and ethnically diverse populations in their studies.

Dr. Cecil Fox/National Cancer Institute

The research will be conducted at six centers: Brigham and Women’s Hospital, Boston; City of Hope/Beckman Research Institute, Duarte, Calif.; Columbia University, New York; Georgetown Lombardi Comprehensive Cancer Center, Washington; Michigan State University, Lansing; University of Massachusetts, Amherst. The research will be coordinated by another center at the University of Wisconsin, Madison.

Breast density is a new area of focus for the NIH. The researchers will consider dense breast tissue as a possible intermediate risk factor for breast cancer with the goal of identifying links between environmental exposures and high breast density, which could provide future prevention strategies.

“These priorities reflect our continued commitment to breast cancer prevention,” Caroline H. Dilworth, Ph.D., BCERP program lead at the National Institute of Environmental Health Sciences, said in a statement. “Our goal is to build on the high-quality science we’ve been funding for more than a decade, while also being responsive to the expert recommendations of the Interagency Breast Cancer and Environmental Research Coordinating Committee] report.”

mschneider@frontlinemedcom.com

On Twitter @maryellenny

Recommended Reading

Genetic biomarkers may be best bet for augmenting mammography screening
MDedge Internal Medicine
DCIS: Recurrence risk rises after forgoing radiotherapy
MDedge Internal Medicine
More genomic instability found in breast tumors of black women
MDedge Internal Medicine
LCIS: 2% annual cancer risk, less than 1% with chemoprevention
MDedge Internal Medicine
DCIS recurrences have declined significantly
MDedge Internal Medicine
ASCO: AIs reduce risk of contralateral breast cancer in patients with BRCA mutation
MDedge Internal Medicine
ASCO: MRI improved breast cancer detection in average risk women
MDedge Internal Medicine
ASCO: Many women with triple-negative breast cancer aren’t screened for BRCA
MDedge Internal Medicine
Computer-aided detection fails to improve mammographic accuracy
MDedge Internal Medicine
VIDEO: When to use MRI in breast cancer
MDedge Internal Medicine